You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Intravitreal bevacizumab improves the clearance of vitreous haemorrhage and visual outcomes in patients with proliferative diabetic retinopathy

Article metrics

Article menu

Download PDFPDF

Original research
Intravitreal bevacizumab improves the clearance of vitreous haemorrhage and visual outcomes in patients with proliferative diabetic retinopathy

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2024

AbstractFullPdf
Dec 2019686539
Jan 202011811655
Feb 202011511523
Mar 202011411417
Apr 2020878714
May 202049496
Jun 2020404111
Jul 2020504911
Aug 2020494912
Sep 2020787414
Oct 2020938717
Nov 2020787812
Dec 2020858311
Jan 202112012030
Feb 2021656217
Mar 202185819
Apr 2021676417
May 2021696910
Jun 202176787
Jul 20214545480
Aug 202111611610
Sep 2021818022
Oct 2021626030
Nov 2021544820
Dec 2021687615
Jan 2022616011
Feb 2022767510
Mar 2022858416
Apr 2022646213
May 2022767616
Jun 2022888413
Jul 2022828319
Aug 202211110212
Sep 2022838520
Oct 2022676114
Nov 2022666610
Dec 202253514
Jan 2023696716
Feb 2023868721
Mar 202359567
Apr 2023484915
May 2023737220
Jun 2023928916
Jul 2023797816
Aug 2023605518
Sep 202381817
Oct 2023818411
Nov 2023848314
Dec 2023484910
Jan 2024373417
Feb 202433329
Mar 2024919239
Total386538031303